Skip to main content

Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study

RAMAT GAN, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced clinical updates and financial results for H1 2026. Advances in Clinical Programs Pancreatic Cancer Phase 2a study evaluating Namodenoson in patients with advanced pancreatic ductal adenocarcinoma achieved its primary safety endpoint and demonstrated durable overall survival outcomes. The open-label Phase IIa study enrolled 20 patients with advanced pancreatic ductal adenocarcinoma who had progressed following standard therapies. Fourteen patients received Namodenoson as third-line treatment, five as second-line treatment, and one as fourth-line treatment. Namodenoson was well...

Continue reading

Raymer Elite Reporting Joins Lexitas

HOUSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) — Lexitas, a leading provider of technology-enabled litigation services and a portfolio company of funds advised by Apax, today announced that Raymer Elite Reporting has joined Lexitas. Founded by Wendy Raymer, Raymer Elite Reporting is a highly respected provider of court reporting and litigation support services, known for its exceptional client service, experienced reporter network, and commitment to delivering accurate and reliable reporting solutions. Serving attorneys, law firms, corporations, and insurers, Raymer Elite has built a strong reputation for professionalism, responsiveness, and quality. “I’m pleased to welcome Raymer Elite Reporting to the Lexitas family,” said Nishat Mehta, CEO of Lexitas. “Wendy has built an outstanding reputation for delivering exceptional service and...

Continue reading

GE Aerospace to Acquire Consolidated Precision Products (CPP), Expanding Mission-Critical Castings Capacity

CINCINNATI, Sept. 08, 2026 (GLOBE NEWSWIRE) —Investing in castings capacity to support strong demand across commercial engines, aftermarket and defense $11.75 billion transaction, expected to be accretive-a) to adjusted EPS* and free cash flow* in the first year Strong near and long-term value creation for customers and shareholdersGE Aerospace (NYSE:GE) announced today that it has signed an agreement to acquire Consolidated Precision Products (CPP), a leading manufacturer of highly engineered castings, from private investment firms Warburg Pincus and Berkshire Partners.  GE Aerospace Chairman and CEO H. Lawrence Culp, Jr., said, “Investing in mission-critical casting capacity is needed to support the strong simultaneous demand across commercial engines, aftermarket and defense. By combining GE Aerospace’s technology capabilities...

Continue reading

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

– Data from a pooled dose group of participants initially enrolled in the multiple ascending dose portion of the trial to be compared against a matched natural history cohort – – Dyne also intends to provide the mean baseline value for video hand opening time (vHOT) in the ACHIEVE registrational expansion cohort (REC) in conjunction with these presentations – – Topline data from the ACHIEVE REC are on track for Q1 2027 – WALTHAM, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that it will present additional one-year clinical data from the Phase 1/2 ACHIEVE trial of zeleciment basivarsen (z-basivarsen, also known...

Continue reading

3 E Network Outlines Full-Stack AI Storage Strategy Across Memory, SSDs and All-Flash Servers

HONG KONG, Sept. 08, 2026 (GLOBE NEWSWIRE) — 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider, committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider, today outlined its strategic initiatives regarding its “Full-Stack AI Storage Business Layout.” As multimodal large models become more prevalent, data throughput requirements are increasing. In response, the Company is coordinating its business lines spanning enterprise memory and storage modules, solid-state drives (“SSDs”), and all-flash storage servers, seeking to establish an integrated hardware platform for massive AI data processing scenarios. This initiative builds on the Company’s efforts over the past...

Continue reading

AGM Group and HashBeaver Jointly Develop Desktop DePIN Node for Bitcoin Mining

The planned device combines Bitcoin mining, DePIN connectivity and AI-assisted device management NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) — AGM Group Holdings Inc. (NASDAQ: AGMH, “AGM Group,” “AGM” or the “Company”), an integrated technology company specializing in high-performance hardware and computing equipment, today announced a joint project with HashBeaver, a digital computing infrastructure company, to develop a new desktop node for decentralized physical infrastructure networks (“DePIN”). The product is intended for use in homes and offices. It is expected to use a purpose-built application-specific integrated circuit (“ASIC”) to perform SHA-256 hashing for Bitcoin mining. Planned software features include device identification, remote management, operational data verification, mining-pool connectivity and artificial intelligence...

Continue reading

Oportun Names Bill Franklin as Chief Financial Officer

Seasoned financial services executive brings deep consumer lending and public markets expertise to advance Oportun’s mission and profitable growth. SAN MATEO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven financial services company, announced that Bill Franklin has joined the Company as Chief Financial Officer, effective today, September 8, 2026. Franklin will lead Oportun’s finance organization and partner with the executive leadership team to advance the Company’s financial strategy, operating discipline, and long-term value creation. “Bill brings an ideal combination of strategic finance leadership and deep consumer financial services experience, alongside a strong understanding of the public markets,” said Doug Bland, Chief Executive Officer of Oportun. “He is...

Continue reading

Clearmind Medicine Receives Yale IRB Approval, Enabling Patient Recruitment for Parts B and C of CMND-100 Phase I/II Trial, Following Positive Safety Results

Vancouver, Canada, Sept. 08, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (the “Company” or “Clearmind”), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment  of neuropsychiatric, metabolic, and addiction disorders including Alcohol Use Disorder (“AUD”), today announced that the Yale University’s IRB has approved the initiation of patient recruitment for Parts B and C of its Phase I/II clinical trial evaluating CMND‑100. This approval advances the multicenter study, titled “A Phase I/II Single and Multiple Dose Tolerability, Safety and Pharmacokinetic Study of CMND‑100 in Healthy Volunteers and Subjects with AUDand directly enables the Company to accelerate enrollment at Yale School of Medicine’s Department of Psychiatry. The Yale site...

Continue reading

SalesCloser Enters Collaboration Agreement with Tendril to Combine Autonomous AI Engagement and Human-Assisted Outbound Dialing

Collaboration pairs SalesCloser’s AI sales agents with Tendril’s human-assisted outbound platform; each company will deploy the other’s solution and train its sales team on the combined offering VANCOUVER, BC, Sept. 08, 2026 (GLOBE NEWSWIRE) — SalesCloser Technologies Ltd. (“SalesCloser” or the “Company”) (TSXV: SCAI) (OTCQB: SCTLF) (FSE: MJ5), a pioneer in autonomous AI sales technology, today announces that it has entered into a collaboration agreement (the “Agreement”) dated September 7, 2026 with Tendril LLC (“Tendril”), a California-based sales acceleration company, to combine SalesCloser’s autonomous AI sales platform with Tendril’s human-assisted outbound dialing, nearshore staffing, and data-enrichment solutions. SalesCloser’s platform deploys AI-powered virtual sales agents that qualify inbound prospects, run product conversations,...

Continue reading

Quantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating System

Establishes In-House AI Backbone at the Company’s Bridgeport, Connecticut Facility; Positions Quantum Cyber as an AI-Native, Vertically Integrated Autonomous Defense Manufacturer Norwalk, CT, Sept. 08, 2026 (GLOBE NEWSWIRE) — Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology company assembling an AI-powered System-of-Systems platform for drone warfare, counter-UAS, and border security applications, today announced that it has acquired a Lambda Hyperplane 8-A100 AI compute cluster, powered by eight NVIDIA A100 Tensor Core GPUs, to serve as the dedicated compute backbone for its Swarm Operating System and for the AI and autonomy features being built into Quantum Station, the Company’s battlefield command-and-control platform. The cluster is intended to be installed...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.